Stocknear Logo Stocknear
/
Popular
Login

Adaptimmune Therapeutics

0.22
-0.01 (-5.70%)
At close: Apr 10, 2025, 10:46 AM

Adaptimmune Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Revenue peaked at - in undefined and hit its lowest at - in undefined. Over the past five years, it has declined by undefined%.

undefined

n/a
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 FY 2018 FY 2017 FY 2016
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
178.03M 60.28M 27.15M 6.15M 3.96M 1.12M 59.51M 37.83M 14.2M
70K 9.86M 127.73M 111.09M 91.57M 97.5M n/a n/a n/a
177.96M 50.42M -100.58M -104.94M -87.61M -96.38M 59.51M 37.83M 14.2M
-68.76M -138.04M -163.97M -162.25M -133.41M -139.77M -82.36M -80.66M -72.8M
6.6M 5.96M 1.54M 1.09M 2.31M 2.77M 2.85M 2.23M 1.11M
-67.24M -112.53M -162.96M -157.3M -129.93M -136.92M -95.02M -69.69M -70.69M
-70.81M -113.87M -165.46M -158.09M -130.09M -137.16M -95.51M -70.14M -71.58M
81.31M 71.81M 63.39M 57.3M 45.8M 43.39M 43.6M 31.11M 23.21M
149.06M 126.51M 127.73M 111.09M 91.57M 97.5M 98.27M 87.39M 63.79M
16.35M n/a -536K 3.85M 1.16M 75K -15.5M 8.74M 1M
246.72M 188.42M 191.11M 168.4M 137.36M 140.89M 141.87M 118.49M 87M
3.35M n/a n/a n/a n/a n/a 376K 2.23M n/a
506K n/a n/a n/a n/a n/a n/a n/a n/a
246.79M 198.28M 191.11M 168.4M 137.36M 140.89M 141.87M 118.49M 87M
3.58M 1.34M 2.5M 791K 162K 242K 497K 451K 892K
1.51B 1.21B 967.24M 934.83M 854.78M 629.81M 584.34M 527.64M 424.71M
1.51B 1.21B 967.24M 934.83M 854.78M 629.81M 584.34M 527.64M 424.71M
-0.05 -0.09 -0.17 -0.17 -0.15 -0.22 -0.16 -0.13 -0.17
-0.05 -0.09 -0.17 -0.17 -0.15 -0.22 -0.16 -0.13 -0.17
-52.66M -128.2M -155.59M -155.68M -125.81M -131.76M -74.56M -75.24M -69.51M
-63.89M -138.04M -161.67M -162.25M -133.41M -139.77M -82.36M -80.66M -72.8M
11.22M 9.84M 6.07M 6.57M 7.65M 8.04M 7.81M 5.42M 3.29M

Create Price Alert on ADAP

Your price alert will notify you when the stock price is above 0.22.

Add to Watchlist